search
Back to results

Effect of Bee Venom Phonophoresis on Healing of Chronic Lower Limb Ulcers

Primary Purpose

Ulcer, Leg

Status
Completed
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
Bee venom phonophoresis
low intensity ultrasound
Sponsored by
Cairo University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Ulcer, Leg

Eligibility Criteria

40 Years - 60 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Eligible patients ranged in age from 40 to 60 years.
  • They had not undertaken another physical therapy modality for ulcer healing
  • non-smokers
  • under their own prescribed medications, and controlled diet therapy as described by their physicians.
  • All patients in the diabetic foot ulcer group (group B) were non-insulin dependent and had controlled blood glucose levels.

Exclusion Criteria:

  • Patients with life-threatening disorders such as renal failure, myocardial infarction.
  • any systemic diseases that may interfere with the study's objectives were excluded.
  • patients with skin disease.
  • any disease that can lead to ulcer rather than diabetes for the diabetic foot ulcer group only, as varicose veins, trauma, peripheral vascular diseases, and/or active malignancy.
  • Ulcer with surface area of less than 2 cm2 or more than 8 cm2 would be excluded from the study.

Sites / Locations

  • Faculty of Physical Therapy

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Sham Comparator

Arm Label

group A

group B

group C

Arm Description

received phonophoresis with Bee Venom gel in form of a noncontact low-frequency pulsed ultrasound delivered through Bee Venom gel as a topical treatment at a distance of between 5 and 15 mm from the ulcer wound bed, and time was 10 minutes for each session in addition to conservative treatment of medical ulcer care.

received phonophoresis with Bee Venom gel in form of a noncontact low-frequency pulsed ultrasound delivered through Bee Venom gel as a topical treatment at a distance of between 5 and 15 mm from the ulcer wound bed, and time was 10 minutes for each session in addition to conservative treatment of medical ulcer care.

received a noncontact low-frequency pulsed ultrasound delivered through only plain gel without BV gel at a distance of between 5 and 15 mm from the ulcer wound bed, and time was 10 minutes for each session in addition to conservative treatment of medical ulcer care.

Outcomes

Primary Outcome Measures

The ulcer surface area
The ulcer surface area would be estimated by placing a piece of sterilized transparency film over the ulcer and using a fine-tipped transparency marker to trace the ulcer perimeter on the film. Each ulcer was treated with its own transparency. The trace was then placed on metric graph paper, and the count of 1mm squares within the perimeter was counted (only entire 1mm squares were counted, and the area was converted to square centimeters)
ulcer volume measurement
The patient would be in a comfortable position, with the ulcer facing upward. To have the longest length and width, the ulcer would be traced on translucent paper and placed over the metric graph paper. A disposable measuring tape would be directed into the deepest point of the ulcer to record the ulcer depth. The volume of the ulcer would be calculated to have the width x length x depth ratio

Secondary Outcome Measures

Full Information

First Posted
February 28, 2022
Last Updated
March 9, 2022
Sponsor
Cairo University
search

1. Study Identification

Unique Protocol Identification Number
NCT05285930
Brief Title
Effect of Bee Venom Phonophoresis on Healing of Chronic Lower Limb Ulcers
Official Title
Effect of Bee Venom Phonophoresis on Healing of Chronic Lower Limb Ulcers
Study Type
Interventional

2. Study Status

Record Verification Date
March 2022
Overall Recruitment Status
Completed
Study Start Date
August 1, 2021 (Actual)
Primary Completion Date
January 20, 2022 (Actual)
Study Completion Date
February 25, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Cairo University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
PURPOSE: to determine the impact of bee venom phonophoresis in accelerating ulcers healing. BACKGROUND: Bee venom (BV) phonophoresis has been suggested as a noninvasive treatment for a number of inflammatory conditions and in healing of ulcers. Ulceration due to vascular causes is often multifactorial and can be caused by both arterial and venous disease. Hypertension and atherosclerosis of the peripheral vessels lead to arterial disease associated with ischemic ulcers. Chronic venous insufficiency and the resulting venous hypertension cause venous ulcers. There are lack in knowledge and information in published studies about the efficacy of bee venom phonophoresis as physical therapy modality in accelerating ulcers healing. So, this study will be designed to provide a guideline about the efficacy of of bee venom phonophoresis in accelerating ulcers healing. HYPOTHESES: It will be hypothesized that: It was hypothesized that Bee venom phonophoresis has no or limited effect in accelerating ulcers healing. RESEARCH QUESTION: Does Bee venom phonophoresis an effect in accelerating ulcers healing?
Detailed Description
• A verbal explanation about the importance of this research procedure, main aims and conceptual approaches were explained to every participant. • Every participant was given his written informed consent for bee venom phonophoresis treatment • The procedures of this study were divided into two main parts: part one (measurement procedures) and part two (treatment procedures). Bee venom allergy test: The participants had been tested for BV allergy; diluted BV, 0.05 ml, in normal saline (1 mg/ml) was injected intra-dermally into the forearm. If the tested lesion resulted in a wheal with a diameter of less than 10 mm and erythema with a diameter of less than 26.5 mm after 10 to 15 minutes, subjects were participated in this study. Measurement procedure: A- Ulcer surface area Ulcer surface (UAS) would be calculated by placing a piece of sterilized transparency film over the ulcer and tracing the ulcer perimeter on the film with fine tipped transparency marker. A separate transparency was used for each Ulcer. The tracing is then placed over metric graph paper and the number of 1mm the tracing was counted (only full 1 millimeter squares inside the perimeter is counted and the area was converted to square centimeters). Ulcer area was measured before the beginning of the study and at the end of the first and second months of therapy and this process was repeated a minimum of three times for each measurement with the value obtained two or more times was reported. B-Ulcer volume measurement in cm3 (width x length x depth): The patient would be positioned in a relaxed position with the ulcer directed upward. The ulcer would be traced on transparent paper and placed over the metric graph paper to have the longest length and width. A measuring tape would be directed into the deepest point of the ulcer to record the ulcer depth. (width x length x depth)would be calculated to have the volume of the ulcer. B-Ulcer volume measurement in cm3 (width x length x depth): The patient would be positioned in a relaxed position with the ulcer directed upward. The ulcer would be traced on transparent paper and placed over the metric graph paper to have the longest length and width. A measuring tape would be directed into the deepest point of the ulcer to record the ulcer depth. (width x length x depth) would be calculated to have the volume of the ulcer Treatment procedures: Participants treated as outpatients, they were given information about the measurement and treatment procedures as well as about the bee venom phonophoresis before the beginning of the treatment, each participant history sheet was taken, they were asked to follow the surgeon and physical therapist instruction and asked to avoid heavy objects lifting as well as smoking. Steps of the bee venom phonophoresis treatment procedures: Position of the participant: Put the participant in the most comfortable and relaxed position which is supine lying position then Remove any clothes above the abdomen to avoid restriction. Ultrasound device preparation: the plug of the ultrasound unit was inserted into the main current supply. Bee venom gel: the treatment approach (phonophoresis application for bee venom gel) had been prepared. Bee venom gel had been used for the study group and pure ultrasound gel had been used for the control group. Each participant received 0.6 mg up to maximum 1 mg BV gel each session • Phonophoresis application for bee venom gel (study group): A pulsed ultrasound (applicator 1.9 cm 2 ) had been applied around the incision site, the movement was over the incision margins with pulsed duty cycle 40% (4 ms on, 6 ms off), and Power density 0.5 W/cm2 and Time was 5 minutes each session. Treatment sessions were 3 sessions a week, for 3 consecutive weeks . Low intensity ultrasound with pure gel (control group): A low intensity pulsed ultrasound (applicator 1.9 cm 2 ) had been applied over the incision margins with pulsed duty cycle 20% (2 ms on, 8 ms off), and Power density 0.8 W/ cm 2 and Time was 5 minutes each session. Treatment sessions were 3 sessions a week, for 3 consecutive weeks 35 and medical treatment.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ulcer, Leg

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
45 (Actual)

8. Arms, Groups, and Interventions

Arm Title
group A
Arm Type
Experimental
Arm Description
received phonophoresis with Bee Venom gel in form of a noncontact low-frequency pulsed ultrasound delivered through Bee Venom gel as a topical treatment at a distance of between 5 and 15 mm from the ulcer wound bed, and time was 10 minutes for each session in addition to conservative treatment of medical ulcer care.
Arm Title
group B
Arm Type
Experimental
Arm Description
received phonophoresis with Bee Venom gel in form of a noncontact low-frequency pulsed ultrasound delivered through Bee Venom gel as a topical treatment at a distance of between 5 and 15 mm from the ulcer wound bed, and time was 10 minutes for each session in addition to conservative treatment of medical ulcer care.
Arm Title
group C
Arm Type
Sham Comparator
Arm Description
received a noncontact low-frequency pulsed ultrasound delivered through only plain gel without BV gel at a distance of between 5 and 15 mm from the ulcer wound bed, and time was 10 minutes for each session in addition to conservative treatment of medical ulcer care.
Intervention Type
Combination Product
Intervention Name(s)
Bee venom phonophoresis
Other Intervention Name(s)
low intensity Ultrasound with bee venom gel
Intervention Description
phonophoresis with Bee Venom gel in form of a noncontact low-frequency pulsed ultrasound delivered through Bee Venom gel as a topical treatment at a distance of between 5 and 15 mm from the ulcer wound bed, and time was 10 minutes for each session in addition to conservative treatment of medical ulcer care. The performance of the ultrasound applicator was tested regularly before and after each patient exposure; each test included all relevant acoustic field parameters (pressure amplitude, frequency) and uniformity of the field distribution. This type of test of the acoustic output of the applicators was important to eliminate the possibility of any malfunctioning of the devices.
Intervention Type
Device
Intervention Name(s)
low intensity ultrasound
Intervention Description
a noncontact low-frequency pulsed ultrasound delivered through plain gel only at a distance of between 5 and 15 mm from the ulcer wound bed, and time was 10 minutes for each session in addition to conservative treatment of medical ulcer care.
Primary Outcome Measure Information:
Title
The ulcer surface area
Description
The ulcer surface area would be estimated by placing a piece of sterilized transparency film over the ulcer and using a fine-tipped transparency marker to trace the ulcer perimeter on the film. Each ulcer was treated with its own transparency. The trace was then placed on metric graph paper, and the count of 1mm squares within the perimeter was counted (only entire 1mm squares were counted, and the area was converted to square centimeters)
Time Frame
changes from baseline, 6 weeks, 12 weeks of therapy.
Title
ulcer volume measurement
Description
The patient would be in a comfortable position, with the ulcer facing upward. To have the longest length and width, the ulcer would be traced on translucent paper and placed over the metric graph paper. A disposable measuring tape would be directed into the deepest point of the ulcer to record the ulcer depth. The volume of the ulcer would be calculated to have the width x length x depth ratio
Time Frame
changes from baseline, 6 weeks, 12 weeks of therapy.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Eligible patients ranged in age from 40 to 60 years. They had not undertaken another physical therapy modality for ulcer healing non-smokers under their own prescribed medications, and controlled diet therapy as described by their physicians. All patients in the diabetic foot ulcer group (group B) were non-insulin dependent and had controlled blood glucose levels. Exclusion Criteria: Patients with life-threatening disorders such as renal failure, myocardial infarction. any systemic diseases that may interfere with the study's objectives were excluded. patients with skin disease. any disease that can lead to ulcer rather than diabetes for the diabetic foot ulcer group only, as varicose veins, trauma, peripheral vascular diseases, and/or active malignancy. Ulcer with surface area of less than 2 cm2 or more than 8 cm2 would be excluded from the study.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
eman othman, professor
Organizational Affiliation
Cairo University
Official's Role
Study Chair
Facility Information:
Facility Name
Faculty of Physical Therapy
City
Giza
ZIP/Postal Code
11432
Country
Egypt

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Data obtained through this study may be provided to qualified researchers with academic interest in bee venom or ulcer . we will share the results of this study within 1 year following publication.
IPD Sharing Time Frame
1 year after publication
IPD Sharing Access Criteria
the criteria will be assessed by the publication of the trial in an international journals.

Learn more about this trial

Effect of Bee Venom Phonophoresis on Healing of Chronic Lower Limb Ulcers

We'll reach out to this number within 24 hrs